HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.

Abstract
Hypovolemic hemorrhagic shock was induced in male anesthetized rats by intermittently withdrawing blood from an iliac catheter over a period of 20 min until mean arterial pressure (MAP) fell to 30 mm Hg. Survival rate, MAP, plasma myocardial depressant factor (MDF) activity and plasma levels of both TxB2 and 6-keto PGF1 alpha were then evaluated. Cloricromene (0.5, 1, and 2 mg/kg) or an equal volume of vehicle (0.9% NaCl solution) were injected intravenously 5 min after the end of the bleeding. Hemorrhagic shocked rats showed enhanced plasma levels of MDF, TxB2 and 6-keto PGF1 alpha. All vehicle-treated rats died within 25 min. Cloricromene (1 and 2 mg/kg) given curatively significantly increased survival rate and blunted the rise in plasma MDF and TxB2. Moreover, cloricromene reversed the severe hypotension and the ST-segment elevation occurring during hemorrhagic shock. The data suggest that cloricromene exerts beneficial effects in experimental hypovolemic shock, probably reversing myocardial failure.
AuthorsR Sturniolo, F Squadrito, G M Campo, R Vinci, A Calatroni, M Prosdocimi, A P Caputi
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 17 Issue 2 Pg. 261-6 (Feb 1991) ISSN: 0160-2446 [Print] United States
PMID1709231 (Publication Type: Journal Article)
Chemical References
  • Myocardial Depressant Factor
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • cloricromen
  • Chromonar
Topics
  • 6-Ketoprostaglandin F1 alpha (blood)
  • Animals
  • Blood Pressure (drug effects)
  • Chromonar (analogs & derivatives, pharmacology)
  • Electrocardiography (drug effects)
  • Male
  • Myocardial Depressant Factor (blood)
  • Rats
  • Rats, Inbred Strains
  • Shock, Hemorrhagic (blood, drug therapy, mortality)
  • Thromboxane B2 (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: